The Effect of AMP Human Sodium Bicarbonate Lotion on Hydration
NCT04598386 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2021-10-14
Summary
The purpose of this research study is to evaluate the effects of a topical sodium bicarbonate lotion on physiological and psychological responses associated with hydration status and fluid balance in humans during passive heat stress. Currently, the ingestion of sodium has been an effective measure for improvements in fluid regulation and hydration status in humans. However, the investigators do not know its regulatory relationship with measurements of fluid balance when supplemented through the skin.
Conditions
- Fluid Retention
- Fluid Loss
- Sodium Retention
- Cognitive Change
- Heat Exposure
- Hyperhydration
- Electrolyte and Fluid Balance Conditions
Interventions
- OTHER
-
PR Lotion - AMP Human Performance
Sodium Bicarbonate Topical Solution. For use of the PR Lotion solution, consumers are instructed to apply the lotion to areas of the body that have been identified as most likely to use during their activity (i.e. calves and thighs for runners, shoulders and forearms for swimmers, etc.). Moreover, the product can be applied up to 2 hours prior to beginning a workout or event with one use supporting a 4-6 hour workout. AMP Human has also verified the safety of their product as being well tolerated in consumers \>2 years of age unless there is a known allergy to an ingredient on the label. Moreover, to the company's knowledge no side effects have been reported per the SAFETY Section at https://amphuman.com/pages/faq.
- OTHER
-
Placebo Lotion
Placebo Topical Solution. Lotion will be created by the AMP Human Performance company and will include all ingredients similar to the PR Lotion product except for the exclusion of sodium bicarbonate.
Sponsors & Collaborators
-
AMP Human; Park City, UT
collaborator UNKNOWN -
United States Department of Defense
collaborator FED -
University of Connecticut
lead OTHER
Principal Investigators
-
Douglas J Casa, PhD · Korey Stringer Institute - UConn
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-12-09
- Primary Completion
- 2021-04-09
- Completion
- 2021-04-09
Countries
- United States
Study Locations
More Related Trials
-
A Pilot Study of Human Amniotic Fluid for COVID19 Associated Respiratory Failure
NCT04319731 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Intravenous Sodium Bicarbonate Verifies Intravenous Position of Catheters in Spontaneously Breathing Adult Volunteers
NCT01458873 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Clinical Trial to Evaluate Safety and Tolerability of a Novel Hydration Drink in Healthy Volunteers
NCT05428748 ·Status: COMPLETED ·Phase: NA
-
Use of Isotonic Solutions Versus Hypotonic Solutions for Preventing Hospital Acquired Hyponatremia
NCT01909336 ·Status: COMPLETED ·Phase: PHASE3
-
Tolvaptan for In-hospital Hyponatremia
NCT01386372 ·Status: TERMINATED ·Phase: PHASE2
-
Biomarkers for Noninvasive Assessment of Human Hydration
NCT01507129 ·Status: COMPLETED
-
Efficacy of Different Oral Rehydration Solutions on the Hydration Status of Healthy Males
NCT05428774 ·Status: COMPLETED ·Phase: NA
-
Small-Volume, Patient-Specific, Balanced Hypertonic Fluid Protocol Validation
NCT03330704 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy (SBT) in Critically Ill Patients
NCT04953013 ·Status: COMPLETED
-
Clinical Study to Evaluate the Effects of Two Novel Hydration Beverage Formulas on Rehydration in Healthy Adults
NCT05428228 ·Status: RECRUITING ·Phase: NA
-
Effect of Glycerol Hyperhydration on Running Economy of Long-distance Runners
NCT06818253 ·Status: COMPLETED ·Phase: NA
-
Effects of Tolvaptan vs Fluid Restriction in Hospitalized Subjects With Dilutional Hyponatremia
NCT01227512 ·Status: TERMINATED ·Phase: PHASE3
-
Oral Fluid Volume Expansion
NCT01360333 ·Status: COMPLETED ·Phase: NA
-
Safety Study of Inhaled Saline in Acute Lung Injury
NCT01713595 ·Status: WITHDRAWN ·Phase: PHASE1
-
To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial)
NCT05060523 ·Status: UNKNOWN ·Phase: NA
-
Low Sodium Diet in Oligohydramnios Assigned for Conservative Management
NCT03815968 ·Status: UNKNOWN ·Phase: NA
-
Low Sodium vs. Regular Diet in Patients Admitted for Heart Failure
NCT02689635 ·Status: TERMINATED ·Phase: NA
-
Relieve the Patient's Thirst, Refresh the Mouth First (ICU-MIC)
NCT03610074 ·Status: COMPLETED ·Phase: NA
-
Influence of Osmotic Stimulation of Vasopressin on Autonomic Function
NCT04233606 ·Status: WITHDRAWN ·Phase: NA
-
Study in Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury
NCT01627613 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Sodium Bicarbonate in Restoring Blocked Catheters
NCT03348826 ·Status: WITHDRAWN ·Phase: PHASE2
-
Sodium Bicarbonate Ringer's Solution Versus Normal Saline for Early Fluid Resuscitation in Patients With Sepsis
NCT04621981 ·Status: UNKNOWN ·Phase: NA
-
Effects of IV Chloride Content on Outcomes
NCT02083198 ·Status: COMPLETED
-
Bicarbonate in Patients With Out-of-hospital Cardiac Arrest
NCT02303548 ·Status: COMPLETED ·Phase: PHASE2
-
Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.
NCT04533997 ·Status: COMPLETED ·Phase: PHASE3